The first and only dual-acting interleukin-23 inhibitor approved in active ulcerative colitis, TREMFYA ®  showed  highly s tatistically significant rates of endoscopic remission at one year in the
The stock market can feel like a roller coaster, especially during economic uncertainty. As fears of a recession increase, investors seek stability and look for investments that can weather the storm
These two companies have been leaders in the healthcare industry for a long time. Both have solid underlying businesses and belong in the group of Dividend Kings.
Pre-medication regimen showed an infusion-related reaction rate of 22.5 percent with intravenous RYBREVANT®, a three-fold reduction from 67.4 percent historically seen with standard IRR management SA
The S&P 500 Dividend Aristocrats list was rebalanced in January 2024, with notable changes including the removal of Walgreens and 3M, and the addition of Fastenal and Kenvue.
Dividend investors looking to really bring home the bacon over an extended time horizon have a number of factors to consider.
The US nonfarm payrolls grew sharply on a month-over-month basis in August but still came in below the consensus forecast on Friday. The US economy added 142,000 jobs last month versus 89,000 in July
New longer-term data from the MARIPOSA study confirm superior outcomes of chemotherapy-free RYBREVANT® plus LAZCLUZE™ regimen compared to osimertinib monotherapy as first-line therapy Results from
This article is part of our monthly series where we highlight five large-cap, relatively safe, dividend-paying companies offering large discounts to their historical norms. We go over our filtering pr

Buy 3 September Dogs Of The Dow; Watch 6

01:00am, Saturday, 07'th Sep 2024
"The Dow® [adds a stock] if the company has an excellent reputation, demonstrates sustained growth, and is of interest to a large number of investors
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, October 15th to review third-quarter results. Joaq
The Investment Committee share their top stocks to watch for the second half.
Johnson & Johnson (NYSE:JNJ ) Wells Fargo 2024 Healthcare Conference September 5, 2024 11:00 AM ET Company Participants Tim Schmid - Executive Vice President, Worldwide Chairman of MedTech Jessica Moo
SANTA CLARA, CA / ACCESSWIRE / September 5, 2024 / MEDevice Silicon Valley, the premier West Coast show connecting medical device engineers and cutting-edge medtech companies, returns to the Santa Cla
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE